NYMXF
PINK Nymox Pharmaceutical Corp$0.0320 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.0320, and at the day’s high of $0.0356
- YTD change
- -20.40%
- vs 20-day SMA
- +27.62%
- vs 200-day SMA
- -52.94%
Price ranges
Price & Performance
-0.03 (-47.54%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 97.5% away from all-time highs of $1.2750
- NYMXF is down 20% since the beginning of the year
- NYMXF is down 51% over the past 12 months
- NYMXF is up 15900% over the past 1 month
- 0% of all NYMXF investors are betting against NYMXF
NYMXF reads n/a: price sits above one of the two key moving averages, the 12-month move is -60.0%.
- Previous minute
- +$0.0000
- Last hour
- -$0.0036
- Last 5 days
- -68.00%
- vs 8-day SMA
- -41.77%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Nymox Pharmaceutical Corp. engages in the research and development of products for the aging population. Its products include NicAlert, TobacAlert and Fexapotide Triflutate for the treatment of low-grade localized prostate cancer. The company was founded by Paul Averback on May 30, 1995 and is headquartered in Nassau, the Bahamas.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.